N.J. Admin. Code 58 app A

Current through Register Vol. 54, No. 7, April 4, 2022

DRUG EFFICACY STUDY IMPLEMENTATION (DESI)

(Update of drug products and known related drug products that lack substantial evidence of effectiveness)

Appendix A at N.J.A.C. 10:51, incorporated herein by reference, is a list of drugs that the Food and Drug Administration (FDA) has proposed to withdraw from the market which is updated periodically by the Centers for Medicare & Medicaid Services (CMS) subsequent to published listing changes in the Federal Register.

AGENCY NOTE: Appendix A is filed as part of this chapter by reference but is not reproduced in the New Jersey Administrative Code. When revisions are made to Appendix A, replacement pages will be distributed to providers and copies will be filed with the Office of Administrative Law. For a copy of Appendix A, access www.njmmis.com or write to:

Gainwell Technologies

PO Box 4801

Trenton, NJ 08650-4801

or contact:

Office of Administrative Law

Quakerbridge Plaza, Building 9

PO Box 049

Trenton, NJ 08625-0049

Notes

N.J. Admin. Code 58 app A
Amended by R.2006 d.338, effective 9/18/2006.
See: 38 N.J.R. 2003(a), 38 N.J.R. 3900(a).
In second paragraph, substituted "Centers for Medicare & Medicaid Services (CMS)" for "Health Care Financing Administration"; and in the Agency Note, deleted "The" before the first occurrence of "Appendix A" and "the" before all other occurrences and inserted "access www.njmmis.com or".
Amended by 53 N.J.R. 1843(c), effective 11/1/2021

The following state regulations pages link to this page.



State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.